ABSI
BEARISH
$2.93
Live
Absci Corporation · NASDAQ
$2.01
52W Range
$5.23
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Mar 24, 2026
Market cap
$440.59M
P/E
N/A
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
N/A
AI Analysis
AI-powered fundamental assessment
Confidence
87%
ABSI's Piotroski F-Score of 0/9 indicates severe financial distress, with no positive signals across profitability, leverage, or cash flow metrics. The absence of an Altman Z-Score and critical financial data (e.g., P/E, ROE, debt/equity) undermines fundamental health assessment. Despite a recent 17.2% weekly price surge and modest EPS growth, the company remains unprofitable with negative forward P/E and no dividend. Insider selling of $0.13M in the last 6 months further signals caution. The stock trades at a premium to book value ($2.93 vs. $1.40 implied book value) without a clear valuation anchor.
Key Strengths
Recent 17.2% weekly price appreciation suggests short-term momentum
Positive Q/Q EPS growth of +16.7% indicates improving earnings trend
Insider sentiment remains moderately positive at 60/100
Historical EPS surprise of +15.3% in Q1 2023 shows occasional outperformance
3-year price return of +70.3% reflects long-term investor interest
Key Risks
Piotroski F-Score of 0/9 signals extreme financial weakness and high distress risk
No available profitability or leverage metrics (ROE, ROA, Debt/Equity) prevent meaningful financial health assessment
Insider selling of $0.13M in last 6 months with no buys indicates bearish sentiment from leadership
Forward P/E of -4.16 confirms sustained unprofitability with no near-term earnings turnaround
No Graham Number or intrinsic value estimate available, making valuation speculative
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
27
Weak
25
45
50
15
0
AI Verdict
Weak
Key drivers: Piotroski F-Score of 0/9, No available profitability or leverage data, Negative forward P/E and unprofitability, Insider selling activity, Lack of analyst coverage
Confidence
85%
Value
25/100
Ref P/E, PEG, Graham Number
Positives
- Price at 52-week low ($2.01) suggests potential undervaluation
Watchpoints
- No Graham Number or intrinsic value available
- Price/Book of 2.09 implies premium valuation despite no earnings
- Forward P/E of -4.16 invalidates traditional valuation metrics
Future
45/100
Ref Growth rates
Positives
- Q/Q EPS growth of +16.7% indicates improving earnings trend
- Recent positive EPS surprises in 2025-08 and 2023-03
Watchpoints
- Persistent unprofitability with negative forward P/E
- No revenue or earnings growth data available
- No analyst estimates or target prices
Past
50/100
Ref Historical trends
Positives
- 3-year price return of +70.3% shows long-term investor interest
- Historical EPS surprise of +15.3% in Q1 2023
Watchpoints
- 5-year price change of -86.4% reflects severe underperformance
- Consistent negative EPS surprises in 2022-2024
- 2021 Q4 surprise of -94.1% indicates extreme miss
Health
15/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Insider sentiment at 60/100 suggests moderate confidence
Watchpoints
- Piotroski F-Score of 0/9 indicates severe financial distress
- No Altman Z-Score available, but absence of key financials raises red flags
- No data on debt, cash, or liquidity ratios
- No operating or free cash flow data
Dividend
0/100
Ref Yield, Payout
Positives
No standout positives identified.
Watchpoints
- Dividend yield and payout ratio are N/A
- No dividend declared or paid
- Company is unprofitable and not dividend-focused
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$2.93
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ABSI and closest competitors.
Updated 2026-03-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ABSI
Absci Corporation
Primary
|
-86.4% | +70.3% | -5.5% | +8.9% | +10.6% | +17.2% |
ABS
Absci Corporation
Primary
5Y
-86.4%
3Y
+70.3%
1Y
-5.5%
6M
+8.9%
1M
+10.6%
1W
+17.2%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
N/A
Forward P/E
-4.16
PEG Ratio
N/A
P/B Ratio
2.09
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
$440.59M
Profitability
Profit margins and return metrics
Profit Margin
N/A
Operating Margin
N/A
Gross Margin
N/A
ROE
N/A
ROA
N/A
Growth
Revenue and earnings growth rates
Revenue Growth
N/A
Earnings Growth
N/A
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q3 2025
Revenue
$0.0B
Op. Margin
-7977.2%
Net Margin
-7594.2%
Total Assets
$0.2B
Liabilities
$0.0B
Equity
$0.2B
Debt/Equity
0.16x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
104%
Quarterly Earnings History
EPS performance vs analyst estimates
2026-03-24
$N/A
2025-11-12
$-0.2
+2.5% surprise
2025-08-12
$-0.24
-15.1% surprise
2025-05-13
$-0.21
+6.0% surprise
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-12 | BUSCH ANDREAS | Officer | Purchase | 100,000 | $229,000 |
| 2026-03-02 | MCCLAIN SEAN | Chief Executive Officer | Stock Award | 406,200 | - |
| 2026-03-02 | MCCLAIN SEAN | Chief Executive Officer | Stock Award | 406,200 | - |
| 2026-03-02 | BEDRICK TODD | Officer | Stock Award | 49,600 | - |
| 2026-03-02 | BEDRICK TODD | Officer | Stock Award | 49,600 | - |
| 2026-03-02 | JONASSON ZACHARIAH | Chief Financial Officer | Stock Award | 135,400 | - |
| 2026-03-02 | JONASSON ZACHARIAH | Chairman of the Board | Stock Award | 135,400 | - |
| 2026-03-02 | WALKER SHELBY J | Officer | Stock Award | 90,300 | - |
| 2026-03-02 | WALKER SHELBY J | Officer | Stock Award | 90,300 | - |
| 2026-03-02 | PANGALOS MENELAS N | Director | Stock Award | 5,800 | - |
| 2026-02-27 | PANGALOS MENELAS N | Director | Purchase | 75,095 | $205,760 |
| 2026-02-23 | MCCLAIN SEAN | Chief Executive Officer | Option Exercise | 396,399 | $479,643 |
| 2026-02-02 | MCCLAIN SEAN | Chief Executive Officer | Sale | 26,761 | $80,015 |
| 2026-02-02 | JONASSON ZACHARIAH | Chairman of the Board | Sale | 17,496 | $52,313 |
| 2026-01-28 | BEDRICK TODD | Officer | Stock Award | 15,000 | - |
BUSCH ANDREAS
Officer
2026-03-12
100,000 shares
·
$229,000
MCCLAIN SEAN
Chief Executive Officer
2026-03-02
406,200 shares
MCCLAIN SEAN
Chief Executive Officer
2026-03-02
406,200 shares
BEDRICK TODD
Officer
2026-03-02
49,600 shares
BEDRICK TODD
Officer
2026-03-02
49,600 shares
JONASSON ZACHARIAH
Chief Financial Officer
2026-03-02
135,400 shares
JONASSON ZACHARIAH
Chairman of the Board
2026-03-02
135,400 shares
WALKER SHELBY J
Officer
2026-03-02
90,300 shares
WALKER SHELBY J
Officer
2026-03-02
90,300 shares
PANGALOS MENELAS N
Director
2026-03-02
5,800 shares
PANGALOS MENELAS N
Director
2026-02-27
75,095 shares
·
$205,760
MCCLAIN SEAN
Chief Executive Officer
2026-02-23
396,399 shares
·
$479,643
MCCLAIN SEAN
Chief Executive Officer
2026-02-02
26,761 shares
·
$80,015
JONASSON ZACHARIAH
Chairman of the Board
2026-02-02
17,496 shares
·
$52,313
BEDRICK TODD
Officer
2026-01-28
15,000 shares
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Needham
2026-03-18
Buy
Buy
HC Wainwright & Co.
2025-12-18
Buy
Buy
Needham
2025-12-12
Buy
Buy
Needham
2025-11-13
Buy
Buy
JP Morgan
2025-10-02
Overweight
Past News Coverage
Recent headlines mentioning ABSI from our newsroom.
Newest → oldest
No matching news yet.